Region

Global opportunities

4 evidence-backed opportunities in Global.

Algorithmic Pricing Governance & Audit Toolkit

Businesses increasingly use algorithmic or AI-assisted pricing, while competition authorities are examining how shared data, common vendors, automated recommendations and personalised pricing can affect competition and consumer outcomes. Operational consequences: A company may be unable to demonstrate what data entered a pricing system, whether staff independently overrode recommendations, which competitors use the same vendor or how a material pricing-model change was reviewed. That creates antitrust and reputational risk even where dynamic pricing itself is legitimate.

AI Procurement Governance Evidence Workspace

Most organisations acquire AI through vendors and procurement rather than building models internally, but conventional purchasing processes are poorly equipped to evaluate probabilistic behaviour, model changes, data use and continuing AI risk. Operational consequences: Legal, procurement, security and operational teams can approve the same AI supplier using different documents and risk frameworks, while evidence becomes stale as models, terms and features change after contract signature.

Trade Exposure and Landed-Cost Scenario Monitor for SMEs

Smaller importers often learn about country, product and tariff exposure through spreadsheets or broker emails. They lack a continuously updated view of how a change in duty, exchange rate, freight or supplier country alters landed cost and margin by SKU. Operational consequences: Late tariff or logistics changes can turn accepted quotes unprofitable, cause price disputes or force rushed sourcing decisions without an auditable assumption history.

Export Diversification Workspace for Small Manufacturers

Small manufacturers can see aggregate trade data and market scores but still have to turn a country ranking into a product-specific action plan: buyer segments, tariff checks, compliance tasks, distributor outreach and evidence for management approval. Operational consequences: Teams can spend on broad market reports without completing compliance, buyer validation or management decisions, leaving concentration risk unchanged.